Fig. 8: Graphical summary of findings.
From: Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia
We report that the pathogenesis of pancreatic cancer cachexia is associated with increased circulating levels of LCN2, which is an anorectic molecule that potentiates muscle and fat wasting associated with cachexia.
